x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DIA-0230333
| Product Information | |
|---|---|
| CAS No. | 38963-95-0 |
| Synonyms | trans-Resveratrol 4'-O-β-D-glucopyranoside |
| Formula | C20H22O8 |
| Molecular Weight | 390.38 |
| Target | Glucosidase/PI3K |
| Product Description | Resveratroloside is a competitive inhibitior of α-glucosidase with an IC50 of 22.9 μM. Resveratroloside has the ability to regulate PBG (postprandial blood glucose) levels. Resveratroloside exhibits cardioprotective effect. |
| Format & Storage | |
|---|---|
| Purity | > 99% |
| Shipping | Shipped on dry ice. |
| Storage | 4 °C, protect from light *In solvent : -80 °C, 6 months; -20 °C, 1 month (protect from light) |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
